Prestige Consumer Healthcare Inc (NYSE:PBH) – Equities researchers at William Blair lowered their Q4 2020 earnings estimates for shares of Prestige Consumer Healthcare in a report issued on Thursday, August 1st, according to Zacks Investment Research. William Blair analyst J. Andersen now forecasts that the company will earn $0.72 per share for the quarter, down from their prior forecast of $0.75.
Several other brokerages also recently issued reports on PBH. TheStreet upgraded shares of Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research note on Tuesday, July 23rd. ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Friday, July 26th. Zacks Investment Research upgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “hold” rating and set a $31.00 price objective on the stock in a research note on Tuesday, May 28th. Finally, CIBC restated a “hold” rating and issued a $84.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, May 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. Prestige Consumer Healthcare currently has a consensus rating of “Hold” and an average target price of $61.07.
PBH stock traded down $0.35 during midday trading on Monday, hitting $32.56. 372,000 shares of the company traded hands, compared to its average volume of 488,081. Prestige Consumer Healthcare has a twelve month low of $26.25 and a twelve month high of $41.76. The company has a quick ratio of 1.26, a current ratio of 2.16 and a debt-to-equity ratio of 1.63. The business has a 50 day simple moving average of $32.55 and a 200-day simple moving average of $30.05. The stock has a market capitalization of $1.68 billion, a price-to-earnings ratio of 11.71, a price-to-earnings-growth ratio of 1.79 and a beta of 0.91.
Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.64 by $0.01. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.81%. The company had revenue of $232.15 million for the quarter, compared to the consensus estimate of $231.52 million. During the same quarter last year, the company posted $0.68 earnings per share. The company’s revenue for the quarter was down 8.6% compared to the same quarter last year.
Several institutional investors have recently added to or reduced their stakes in the stock. Financial Gravity Wealth Inc. bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth about $50,000. Quadrant Capital Group LLC raised its holdings in Prestige Consumer Healthcare by 2,979.3% during…